PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.04%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-35.12%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-142.19%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-142.19%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-188.64%
Negative net income growth while MTDR stands at 772.97%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-188.65%
Negative EPS growth while MTDR is at 700.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-188.65%
Negative diluted EPS growth while MTDR is at 700.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.69%
Dividend growth of 7.69% while MTDR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
6.99%
Positive OCF growth while MTDR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-710.53%
Negative FCF growth while MTDR is at 19.84%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-78.32%
Negative 10Y revenue/share CAGR while MTDR stands at 518.05%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-71.35%
Negative 5Y CAGR while MTDR stands at 255.43%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-50.31%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-87.61%
Negative 10Y OCF/share CAGR while MTDR stands at 173.14%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-84.62%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-62.95%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-144.94%
Negative 10Y net income/share CAGR while MTDR is at 4564.75%. Joel Greenblatt sees a major red flag in long-term profit erosion.
2.01%
Below 50% of MTDR's 1271.37%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
3.70%
Below 50% of MTDR's 368.19%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-63.08%
Negative equity/share CAGR over 10 years while MTDR stands at 4.56%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-67.81%
Negative 5Y equity/share growth while MTDR is at 14.33%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
2.38%
Positive short-term equity growth while MTDR is negative. John Neff sees a strong advantage in near-term net worth buildup.
-81.06%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-91.83%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-69.12%
Negative near-term dividend growth while MTDR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-33.40%
Firm’s AR is declining while MTDR shows 12.41%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.52%
Asset growth well under 50% of MTDR's 24.37%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-1.70%
We have a declining book value while MTDR shows 55.18%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.09%
Debt shrinking faster vs. MTDR's 25.54%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-9.90%
We cut SG&A while MTDR invests at 18.54%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.